- Home
- IPHA vs STRS Comparison
IPHA vs STRS Comparison
Compare IPHA & STRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- STRS
- Stock Information
- Founded
- IPHA 1999
- STRS 1992
- Country
- IPHA France
- STRS United States
- Employees
- IPHA N/A
- STRS N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- STRS Homebuilding
- Sector
- IPHA Health Care
- STRS Real Estate
- Exchange
- IPHA Nasdaq
- STRS Nasdaq
- Market Cap
- IPHA 160.1M
- STRS 133.9M
- IPO Year
- IPHA 2019
- STRS N/A
- Fundamental
- Price
- IPHA $2.18
- STRS $18.74
- Analyst Decision
- IPHA Strong Buy
- STRS
- Analyst Count
- IPHA 1
- STRS 0
- Target Price
- IPHA $11.00
- STRS N/A
- AVG Volume (30 Days)
- IPHA 28.8K
- STRS 7.2K
- Earning Date
- IPHA 03-27-2025
- STRS 05-15-2025
- Dividend Yield
- IPHA N/A
- STRS N/A
- EPS Growth
- IPHA N/A
- STRS N/A
- EPS
- IPHA N/A
- STRS N/A
- Revenue
- IPHA $20,831,349.00
- STRS $32,719,000.00
- Revenue This Year
- IPHA $209.83
- STRS N/A
- Revenue Next Year
- IPHA $83.15
- STRS N/A
- P/E Ratio
- IPHA N/A
- STRS N/A
- Revenue Growth
- IPHA N/A
- STRS N/A
- 52 Week Low
- IPHA $1.29
- STRS $15.10
- 52 Week High
- IPHA $3.51
- STRS $30.66
- Technical
- Relative Strength Index (RSI)
- IPHA 53.46
- STRS 48.06
- Support Level
- IPHA $2.06
- STRS $17.00
- Resistance Level
- IPHA $2.24
- STRS $19.20
- Average True Range (ATR)
- IPHA 0.09
- STRS 1.05
- MACD
- IPHA -0.01
- STRS -0.19
- Stochastic Oscillator
- IPHA 53.33
- STRS 27.19
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About STRS Stratus Properties Inc.
Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations. Real Estate Operations segment encompasses activities associated with entitlement, development, and sale of real estate. Leasing Operations segment involves leasing of commercial space at retail and mixed-use properties and residences in multi-family properties that company developed. Majority of revenue is from Real Estate Operations.